Used as an intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical research targeting central nervous system disorders such as antidepressants and mood stabilizers. Its structure, featuring a sulfonyl piperazine with a trifluoromethyl-substituted phenyl group, supports the development of selective receptor modulators, especially for serotonin and dopamine receptors, by enhancing blood-brain barrier penetration and receptor specificity. Commonly employed in medicinal chemistry for optimizing drug candidates due to its favorable conformational and electronic properties. Also utilized in the preparation of chiral catalysts and asymmetric synthesis applications.